Maintenances
Also known as: Maintenance
Drug | Drug Name | Drug Description |
---|---|---|
DB05039 | Indacaterol | An inhaled long-acting beta-2 adrenergic agonist used to relax bronchial smooth muscle and improve symptoms and airflow obstruction caused by Chronic Obstructive Pulmonary Disease (COPD) and moderate to severe asthma. |
Drug | Drug Name | Target | Type |
---|---|---|---|
DB05039 | Indacaterol | Beta-2 adrenergic receptor | target |
DB05039 | Indacaterol | Cytochrome P450 3A4 | enzyme |
DB05039 | Indacaterol | UDP-glucuronosyltransferase 1-1 | enzyme |
DB05039 | Indacaterol | P-glycoprotein 1 | transporter |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB15765 | Sintilimab | 2 | Unknown Status | 1 |
DB09570 | Ixazomib | Not Available | Recruiting | 1 |
DB00480 | Lenalidomide | Not Available | Recruiting | 1 |